All posts tagged "DCGI"
-
455NewsDCGI Gives Nod to Cipla to Import Moderna’s Covid-19 Vaccine for Emergency Use Authorisation
Mumbai-headquartered pharma major Cipla has got a nod from The Drugs Controller General of India (DCGI) on Tuesday for importing Moderna’s Covid-19...
-
884NewsCSIR, Laxai Life Sciences Receives Regulatory Approval for Colchicine Clinical Trials on Covid-19 Patients
Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt Ltd Hyderabad has been given the regulatory approval by DCGI...
-
981NewsOptimus Pharma Gets DCGI Nod for Conducting Phase-III Clinical Trials for Molnupiravir on Mild-to-Moderate Covid Patients
Optimus Pharma on Wednesday received DCGI nod for conducting phase-III clinical trials for orally-administered Molnupiravir capsules on patients with mild-to-moderate Covid-19 patients....
-
508CoronavirusOver 1.1 Cr Indians Vaccinated So far
At least 1,10,85,173 beneficiaries have been vaccinated for Covid-19 through 2,30,888 sessions in the country, according to a provisional report of the...
-
1.3KNewsDCGI okays phase-1 human trials of ‘antisera’ with potential to treat COVID-19
The DGCI (Drugs Controller General of India), the apex healthcare research body has given approval for conducting Phase-1 human clinical trial for...
-
1.4KNewsSerum-Oxford covid-19 vaccine gets DCGI nod for phase 2, 3 trials in India
The Serum Institute of India (SII) has received approval from Drug Controller General of India (DCGI) to move ahead for phase 2...
-
1.9KNewsMylan gets DCGI approval for anti-TB drug Pretomanid
Mylan, a global pharmaceutical company, today announced that the Drug Controller General of India (DCGI) has approved the anti-tuberculosis drug pretomanid for...
-
1.2KNewsDCGI nod to Pneumococcal Polysaccharide Conjugate Vaccine
Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine. This vaccine has...
-
1.3KNewsDCGI gives nod for restricted emergency use for Itolizumab in COVID-19 treatment
India’s drug regulator has approved Itolizumab, a medicine used to cure severe plaque psoriasis for “restricted emergency use” to treat COVID-19 patients...
-
1.3KNewsCOVID-19: Biocon’s medical device gets DCGI nod to treat critical patients
The Drugs Controller General of India (DCGI) has given go-ahead to a medical device of Biocon Biologics to treat critical COVID-19 patients....
-
2.3KNewsDCGI nod to Zydus Cadila for world’s first drug to treat liver disease
The Ahmedabad-based drug major Zydus Cadila has said that it received approval from the Drug Controller General of India (DCGI) for its...
-
2.9KNewsGovt brings new rules for drugs and clinical trials
In a bid to promote clinical research in India, the Union Ministry of Health & Family Welfare has come up with ‘New...